|
|
|
|
Дата |
|---|
| 21.08.2026 |
| 20.08.2026 |
| 19.08.2026 |
| 18.08.2026 |
| 17.08.2026 |
| 14.08.2026 |
| 13.08.2026 |
| 12.08.2026 |
| 11.08.2026 |
| 04.08.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
36 900.00
|
36 800.00
|
37 000.00
|
36 900.00
|
|
|
225 000 000.00
|
|
|
|
|
37 000.00
|
36 500.00
|
37 600.00
|
37 600.00
|
|
|
47 730 000.00
|
|
|
|
|
37 000.00
|
36 900.00
|
37 000.00
|
36 950.00
|
|
|
81 390 000.00
|
|
|
|
|
37 700.00
|
37 000.00
|
37 700.00
|
37 000.00
|
|
|
74 760 000.00
|
|
|
|
|
36 500.00
|
36 500.00
|
37 700.00
|
37 700.00
|
|
|
82 390 000.00
|
|
|
|
|
37 900.00
|
36 000.00
|
37 900.00
|
37 700.00
|
|
|
93 190 000.00
|
|
|
|
|
37 200.00
|
37 200.00
|
37 800.00
|
37 700.00
|
|
|
116 420 000.00
|
|
|
|
|
37 800.00
|
37 050.00
|
37 800.00
|
37 200.00
|
|
|
183 400 000.00
|
|
|
|
|
37 900.00
|
37 800.00
|
37 900.00
|
37 800.00
|
|
|
162 780 000.00
|
|
|
|
|
37 900.00
|
37 900.00
|
37 900.00
|
37 900.00
|
|
|
34 110 000.00
|
|
Период |
|---|
| 2025, регулярные |
| 2025, регулярные |
| 2024, регулярные |
| 2023, регулярные |
| 2023, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
21.07.2026
|
22.07.2026 |
2000 VND |
|
31.12.2025
|
05.01.2026 |
2000 VND |
|
13.06.2025
|
16.06.2025 |
2000 VND |
|
17.06.2024
|
18.06.2024 |
2000 VND |
|
16.01.2024
|
17.01.2024 |
2000 VND |
|
19.01.2021
|
20.01.2021 |
2000 VND |
|
01.01.2020
|
02.01.2020 |
2000 VND |
|
04.01.2019
|
07.01.2019 |
2000 VND |
|
27.12.2017
|
28.12.2017 |
2000 VND |
|
03.01.2017
|
04.01.2017 |
2000 VND |
Traphaco JSC is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry.
